CH679553A5 - - Google Patents

Download PDF

Info

Publication number
CH679553A5
CH679553A5 CH2511/89A CH251189A CH679553A5 CH 679553 A5 CH679553 A5 CH 679553A5 CH 2511/89 A CH2511/89 A CH 2511/89A CH 251189 A CH251189 A CH 251189A CH 679553 A5 CH679553 A5 CH 679553A5
Authority
CH
Switzerland
Prior art keywords
methyl
pharmaceutical composition
carbazol
tetrahydro
use according
Prior art date
Application number
CH2511/89A
Other languages
English (en)
French (fr)
Inventor
Keith Thomas Bunce
Patrick Paul Anthony Humphrey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CH679553A5 publication Critical patent/CH679553A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH2511/89A 1988-07-07 1989-07-06 CH679553A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816187A GB8816187D0 (en) 1988-07-07 1988-07-07 Medicaments

Publications (1)

Publication Number Publication Date
CH679553A5 true CH679553A5 (xx) 1992-03-13

Family

ID=10640032

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2511/89A CH679553A5 (xx) 1988-07-07 1989-07-06

Country Status (14)

Country Link
US (1) US4983621A (xx)
JP (1) JPH0276815A (xx)
AU (1) AU633496B2 (xx)
BE (1) BE1002295A5 (xx)
CA (1) CA1330306C (xx)
CH (1) CH679553A5 (xx)
DE (1) DE3922263A1 (xx)
DK (1) DK336489A (xx)
FR (1) FR2633831B1 (xx)
GB (2) GB8816187D0 (xx)
IT (1) IT1232155B (xx)
NL (1) NL8901727A (xx)
SE (1) SE8902458L (xx)
ZA (1) ZA895142B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
US7098345B2 (en) * 2002-04-29 2006-08-29 TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
AU2003257060A1 (en) * 2002-07-31 2004-02-16 Sepracor Inc. Cyclooxygenase-2 inhibitors for appetite suppression
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB105193A (en) * 1916-08-29 1917-04-05 Thomas Joseph Mills Improvements in Rotary Printing Machines.
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
NL8901727A (nl) 1990-02-01
AU633496B2 (en) 1993-02-04
IT1232155B (it) 1992-01-25
US4983621A (en) 1991-01-08
CA1330306C (en) 1994-06-21
SE8902458L (sv) 1990-01-08
GB8816187D0 (en) 1988-08-10
DK336489D0 (da) 1989-07-06
DK336489A (da) 1990-01-08
JPH0276815A (ja) 1990-03-16
AU3790489A (en) 1990-01-11
GB2220352B (en) 1992-03-18
IT8948163A0 (it) 1989-07-06
FR2633831B1 (fr) 1993-11-19
ZA895142B (en) 1990-06-27
SE8902458D0 (sv) 1989-07-06
DE3922263A1 (de) 1990-01-11
FR2633831A1 (fr) 1990-01-12
BE1002295A5 (fr) 1990-11-20
GB2220352A (en) 1990-01-10
GB8915499D0 (en) 1989-08-23

Similar Documents

Publication Publication Date Title
CH672068A5 (xx)
FR2673538A1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
CH642635A5 (fr) Derives de l'imidazole, procedes pour leur preparation et compositions medicamenteuses contenant ces derives.
BE1007268A3 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
CA2153341A1 (fr) Application de la carbamazepine et de l'oxcarbazepine dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
CH679553A5 (xx)
FR2837706A1 (fr) Utilisation d'un antagoniste des recepteurs aux cannabinoides cb1 pour la preparation de medicaments utiles pour traiter les dysfonctionnements sexuels et/ou ameliorer les performances sexuelles
CH678149A5 (xx)
RU2164795C2 (ru) Применение n-(пиридинил)-1h-индол-1-аминов для получения медикамента для лечения обсессивно-компульсивных расстройств
JPH01316319A (ja) 医薬
WO2000061125A2 (fr) L'osanetant dans le traitement des troubles de l'humeur
EP1682124B1 (fr) Compositions pharmaceutiques a base de sel d'idazoxan ou d´un de ses polymorphes
FR2705569A1 (fr) Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.
JPH10511931A (ja) 非インシュリン依存性糖尿病の患者において胃空腹を抑制する１，５−ベンゾジアゼピン誘導体の使用
FR2544614A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
CH674008A5 (xx)
JPS63211227A (ja) 医薬
FR2512343A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
FR2512342A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
FR2623713A1 (fr) Composition pharmaceutique destinee au traitement de troubles gastro-intestinaux
FR2792834A1 (fr) Utilisation du sr 49059, de ses solvats et/ou hydrates pharmaceutiquement acceptables, pour la preparation de medicaments utiles dans le traitement ou la prevention du phenomene de raynaud
BE880020A (fr) Nouveau compose d'imidazole et agent antidepressif contenant ce compose
JP2000507569A (ja) 抗精神病薬ならびに鎮痛薬を製造するための、１，１―ジアルキル―１，２，３，４―テトラヒドロイソキノリンの使用

Legal Events

Date Code Title Description
PL Patent ceased